Court of the Hague and EMA Confirmed for C5's Summit on Biosimilars and Originator Biologics

MUNICH - Oct. 17, 2022 - PRLog -- C5 Communications is pleased to announce that Judge Margot Kokke, District Court Judge of the Court of The Hague (The Netherlands) and Steffen Thirstrup, Affiliate Professor, Chief Medical Officer of European Medicines Agency are confirmed to speak at C5's International Summit on Biosimilars and Originator Biologics taking place at the Hilton Munich Park on 1-2 December, 2022.

In addition to these esteemed presenters, this year's faculty includes respected in-house counsel from Sandoz, STADA Arzneimittel A G, Fresenius Kabi, Alkermes and more.

Sharada F. Devarasetty, 2022 Co-Chair and Head of Patents - Biopharmaceuticals at Sandoz, commented that, "We are excited to share the latest trends in the biosimilar and biologics industries as well as to take advantage of the opportunity to network, brainstorm, and discuss."

In addition, Dr. Christine Berndt, 2022 Co-Chair and VP, Global Head Development Specialty/Biosimilars at STADA Arzneimittel A G, added, "This C5 summit will provide a unique opportunity to listen to a panel of international experts that jointly work on the global challenges Biologic Originators and Biosimilar Developers are facing."

In response, Lisa J. Piccolo, Associate VP with C5, noted, "we are honored to have Judge Margot Kokke, Steffen Thirstrup, Sharada F. Devarasetty, Dr. Christine Berndt and all of our distinguished speakers participate in this year's conference. Their presence at the event is a testament to the "must-attend" status of this conference for all life sciences practitioners involved in the originators and biosimilars process."

Joseph Gallagher, Esq., Director, Content Life Sciences IP at C5, remarked, "We are proud to host the premier event for biopharmaceutical stakeholders to gather and develop a holistic legal and regulatory strategy for maximizing commercial results for your products."

Full information on the forum can be found at https://bit.ly/3s3ofAS

# (https://www.c5-online.com/biosimilars-biologics/)##

A unique organization, C5 Group Inc. is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the U.S., and around the world.

Staffed by industry specialists, lawyers, and other professionals, C5 Group Inc. operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.